cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2006; 47:1997-2004, doi:10.1016/j.jacc.2006.01.060 (Published online 24 April 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olsson, L. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olsson, L. G.

Atrial Fibrillation and Risk of Clinical Events in Chronic Heart Failure With and Without Left Ventricular Systolic Dysfunction

Results From the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) Program

Lars G. Olsson, MB*, Karl Swedberg, MD, PhD, FACC*,*, Anique Ducharme, MD, MSc{dagger}, Christopher B. Granger, MD, FACC{ddagger}, Eric L. Michelson, MD, FACC§, John J.V. McMurray, MD, FACC||, Margareta Puu, PhD, Salim Yusuf, MD, DPhil, FACC#, Marc A. Pfeffer, MD, PhD, FACC** on behalf of the CHARM Investigators

* Department of Medicine, Sahlgrenska University Hospital/Östra, Göteborg, Sweden
{dagger} Research Center, Montreal Heart Institute, Montreal, Quebec, Canada
{ddagger} Duke University Medical Center, Durham, North Carolina
§ AstraZeneca LP, Wilmington, Delaware
|| Department of Cardiology, Western Infirmary, Glasgow, Scotland
AstraZeneca, Mölndal, Sweden
# HGM-McMaster Clinic, Hamilton, Ontario, Canada
** Brigham and Women's Hospital, Boston, Massachusetts


Figure 1
View larger version (27K):

[in a new window]
 
Figure 1 Risk of baseline atrial fibrillation (AF) for cardiovascular (CV) events depending on ejection fraction (EF). CHF = chronic heart failure.

 

Figure 2
View larger version (14K):

[in a new window]
 
Figure 2 Time to cardiovascular (CV) death or hospitalization because of heart failure. AF = atrial fibrillation; EF = ejection fraction; PEF = preserved left ventricular ejection fraction.

 

Figure 3
View larger version (14K):

[in a new window]
 
Figure 3 Time to all-cause mortality. AF = atrial fibrillation; CI = confidence interval; EF = ejection fraction; PEF = preserved left ventricular ejection fraction.

 

Figure 4
View larger version (28K):

[in a new window]
 
Figure 4 Risk of new-onset atrial fibrillation (AF) for cardiovascular (CV) events depending on ejection fraction (EF). CHF = chronic heart failure.

 

Figure 5
View larger version (23K):

[in a new window]
 
Figure 5 Treatment effects depending on baseline heart rhythm in CHARM-Overall. AF = atrial fibrillation; CHF = chronic heart failure; CV = cardiovascular.

 




 
  cardiology careers collections past issues search home